Week 10 & 11: Cancer Biology & Management Flashcards

1
Q

Discuss the etiology of cancer including genetic, epigenetic, environmental, and lifestyle factors.

A

Environment-lifestyle behaviors and genetic factors contribute to the formation of cancers. Cancer is driven by genetic alterations and changes in epigenetic regulation. The development of cancer and its progression involve the tissue microenvironment or stroma, where infiltrating immune cells cause chronic inflammation, creating a permissive tumor-progressing environment. Factors that influence cancer risk include:
*Detoxifying enzymes
*DNA repair genes
*Immune/inflammatory systems
*Cell’s immediate environment
*Metabolic/hormonal factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the pathophysiologic processes of cancer that affect cells and contrast with normal cellular functioning

A

Cancer is a complex disease, and the microenvironment of a tumor is a heterogeneous mixture of cells, both cancerous and benign. Cancer is a disease of cumulative genetic changes during aging. Genetic changes involve mutational and epigenetic mechanisms. Mutation means an alteration in the DNA sequence affected expression or function of a gene. Mutations include point mutations, chromosome translocations, and gene amplification. Epigenetic effects can alter gene expression indirectly and include DNA methylation, histone acetylation, or altered expression of non-coding RNA. DNA mutations “drive” the progression of cancer, but not all mutations in cancer contribute to the malignant phenotype - some are just random events, called passenger mutations. After a critical number of mutations has occurred, a cell becomes cancerous.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a benign neoplasm?

A

Benign tumors are usually encapsulated with connective tissue and contain fairly well-differentiated cells and well-organized surrounding supportive tissue called stroma. They retain recognizable normal tissue structure and do not invade beyond their capsule, nor do they spread to regional lymph nodes or distant locations. Benign tumors are generally named according to the tissues from which they arise with the suffix “-oma”, which indicates a tumor or mass. Benign tumors can still become extremely large and, depending on their location in the body, can cause morbidity or be life-threatening. Some tumors initially described as benign can progress to cancer and then are referred to as malignant tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List & describe the 10 hallmarks of cancer.

A
  1. Avoiding Immune Destruction: active inflammation pre-disposes individuals to cancer but also stimulates a wound-healing response that supports tumor growth. Also includes the immune surveillance hypothesis and the immunotherapy hypothesis.
  2. Evading growth suppressors: evasion of the genes responsible for inducing and suppressing growth
  3. Enabling replicative immortality: cancer cells can activate telomerase, leading to continued division.
  4. Tumor-promoting inflammation
  5. Activating invasion and metastasis
  6. Genomic instability (mutator phenotype): involves the mutation of genes involved in regulating cell growth
  7. Inducing angiogenesis: advanced cancers can secrete angiogenic factors to facilitate feeding of the tumor.
  8. Resisting cell death: apoptotic pathways are dysregulated in most cancers
  9. Deregulating cellular energetics
  10. Sustaining proliferative signaling: involves uncontrolled cellular proliferation where cytoplasmic components of the receptors activate intracellular signaling pathways that induce/activate regulatory factors that affect DNA synthesis, entrance into the cell cycle, and changes in expression of other genes related to cell metabolism for optimal growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss and differentiate between local invasion versus distant spread of cancer.

A

Metastasis is the spread of cancer cells from the site of the original tumor to distant tissues and organs through the body. Metastasis is a defining characteristic of cancer and is the main cause of death from cancer. The process of metastases requires cancer cells to leave their primary site, circulate in the bloodstream, withstand pressure in the blood vessels, thrive in the new cellular surroundings, and escape “destruction” by immune cells. Unfortunately, communications with the tumor microenvironment allow invading cancer cells to conquer stromal challenges, settle, and colonize. Characteristics are driven by genetics and epigenetic changes within the tumor cell itself and its microenvironment. Invasion involves evolution of new abilities in cancer cells that facilitate metastasis (i.e., EMT) and starts with tumor extension and then eventually migration away from the primary tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is cancer?

A

A disease in which some of the body’s cells begin to divide without stopping and spread into surrounding tissues. The term cancer comes from the Latin translation of the Greek word for crab, karkinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a tumor?

A

Describes new growth or neoplasm. Neoplasms result from an abnormal growth following uncontrolled proliferation serving no physiologic purpose. Not all tumors or neoplasms, however, are cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a malignant neoplasm?

A

Malignant tumors are distinguished from benign tumors by more rapid growth rates and specific microscopic alterations, including **loss of differentiation ** and absence of normal tissue organization.

One of the microscopic hallmarks of cancer cells is anaplasia, the loss of cellular differentiation. Malignant cells are also pleomorphic, with marked variability of size and shape. They often have large, darkly stained nuclei, and mitotic cells are common. Malignant tumors may have a substantial amount of stroma, but it is disorganized, with loss of normal tissue structure.

The most important and most deadly characteristic of malignant tumors is their ability to spread far beyond the tissue of origin, a process known as metastasis.

Unlike benign tumors, which are named related to the tissue or origin, cancers generally are named according to the cell type from which they originate. Cancers arising in epithelial tissue are called carcinomas, and if they arise from ductal or glandular structures they are named adenocarcinomas. Cancers arising from mesenchymal tissue (including connective tissue, muscle, and bone) usually have the suffix sarcoma. Cancers of lymphatic tissue are called lymphomas, whereas cancers of blood-forming cells are called leukemias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss the impact of tobacco and cigarette smoking in cancer development.

A

The main inducer of both lung cancer and chronic obstructive pulmonary disease (COPD) is cigarette smoke. Cigarette smoke induces an inflammatory response and causes an increase in reactive oxygen species (ROS), causing oxidative stress. Oxidative stress is a risk factor for many diseases because it can alter many cellular proteins. A combination of immune inflammatory signals and epigenetic events may increase the risk for individuals with COPD developing lung cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss the impact of diet on cancer development.

A

*Nutrition may influence the regulation of the normal cell cycle, which ensures correct DNA replication. *However, dietary components can also act directly as mutagens or interfere with the elimination of mutagens. Xenobiotics that include toxic, mutagenic, and carcinogenic chemicals are found in many foods and medications.

Certain enzymes (glutathione-S-transferases GSH) are “enzyme housekeepers” that play essential roles in the metabolism of environmental carcinogens and reactive oxygen species (ROS). Individuals who have absent or reduced levels of these protective enzymes may be at higher risk for cancers because of a decreased capacity to effectively neutralize carcinogens by metabolic transformation into less toxic forms.

Additionally, DNA requires methylation to properly regulate gene expression. Diets lacking in the dietary donors may struggle with methylation. Primary donors include: folate, choline, and B vitamins. Altered micro-ribonucleic acid (miRNA) may additionally predispose an individual to cancer. Consuming kiwi fruits, cooked carrots, or supplemental coenzyme Q10 may improve DNA repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss the impact of obesity on cancer development.

A

Obesity has been linked mechanistically to both an increase in cancer risk and cancer progression. Because tumor growth is regulated by interactions between tumor cells and their tissue microenvironment, stromal compartments rich in adipose tissue can promote the development of tumor cells. During cancer progression, cancer-associated adipocytes (CAAs) undergo both structural and functional alterations that create a favorable micro-environment for increased cellular invasiveness and aggression. Cancer cells alter adipocytes through lipolysis and dilapidation leading to CAAs that produce abnormal amounts of adipocyte-derived cytokines (increased leptin and decreased adiponectin), as well as release inflammatory cytokines and protease enzymes. The adipokine leptin increases inflammation and is associated with stromal effects that promote cancer cell proliferation, metabolism, angiogenesis, and invasion. In obese individuals, changes in glucose and lipid metabolism are found in the tumor microenvironment as well as systemically. Obesity causes dysfunctional adipose tissue to produce increased levels of insulin-like growth factor (IGF-1), sex-hormones, and adipokines that contribute to obesity-related metabolic changes such as insulin resistance, hyperglycemia, dyslipidemia, hypoxia, and chronic inflammation. As described previously, inflammation is an important contributor to both tumor initiation and progression. Excess adipose tissue can become reservoirs of lipophilic organochlorines and other fat-seeking toxic agents that can enhance proinflammatory mediators, which attract macrophages and cancer-associated fibroblasts, all of which are tumor-promoters. Additionally, the associated insulin resistance and hypoxia can trigger compensatory angiogenesis, thus providing an energy reservoir for any embedded cancer cells. Type 2 diabetes, elevated insulin levels, and altered insulin signaling pathways in obese individuals have been linked to cancer risk and progression as well as resistance to cancer therapies.

There are currently 13 cancers associated with overweight and obesity:
- Meningioma
- Adenocarcinoma
- Multiple myeloma
- Kidneys
- Uterus
- Ovaries
- Thyroid
- Breast
- Liver
- Gallbladder
- Upper stomach
- Pancreas
- Colon and rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the impact of alcohol consumption on cancer development.

A

Alcohol is classified by IARC as a human carcinogen and is known to increase circulating unbound hormones as well as obesity. Overall, there are strong data linking alcohol with cancers of the mouth, pharynx, larynx, esophagus, liver, colorectum, and breast (in both males and females). The evidence does not support any “safe limit” of intake. The deleterious effects come from the ethanol content and are not affected by the type of drink consumed. Acetaldehyde is the most toxic metabolite of alcohol and is the chief cause of alcohol-related carcinogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss the impact of air pollution on cancer development.

A

Air pollution is specifically linked to lung cancer and can be caused by outdoor or indoor pollution. Outdoor pollution includes particle pollution which causes pulmonary inflammation, oxidative stress, and oxidation of DNA, which can result in nonfatal heart attacks, irregular heartbeat, and decreasing lung function. Indoor pollution includes cigarette smoke and radon and is considered worse than outdoor pollution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss the impact of radiation on cancer development.

A

Ionizing radiation is a potent DNA-damaging agent causing cross-linking, nucleotide base damage, and single-or double-strand DNA breaks thus disrupting cellular regulation processes leading to carcinogenesis. from x-ray machines, radioisotopes, and other radioactive sources can result in acute leukemias, increased frequencies of thyroid and breast carcinomas, lung, stomach, colon, esophageal, and urinary tract cancers. Radiation enters cells and randomly deposits energy in tissue resulting in oncogene activation, tumor-suppressor genes deactivation, chromosomal aberrations, and DNA damage, as well as cell transformation.

Non-ionizing radiation includes electromagnetic radiation and differs from IR in the way it acts on materials like air, water, and living tissue. NIR includes the spectrum of UV, visible light, infrared, microwave, radio frequency, and extremely low frequency. EMR originating in the UV part of the spectrum and above can interact with material leading to the direct ionization of atoms and molecules and is considered to pose a health risk.

UV radiation is principally caused by sunlight and results in basal cell carcinoma, squamous cell carcinoma, and melanoma.

Lastly, electromagnetic radiation (EMR) is energy in the form on transverse magnetic and electric waves and includes microwaves, radar, mobile and cellular telephones/base stations, appliances, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the impact of infections on cancer development.

A

Among the more notable infections contributing to new cancer cases are Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Epstein-Barr virus (EBV). H.pylori contributes to about 75% of stomach cancers. HPV, HBV, and HCV infect the liver and together account for the preponderance of liver cancer cases. EBV is linked to nasopharyngeal carcinoma, Hodgkin lymphoma, diffuse large B-cell lymphoma, Burkitt lymphoma, EBV-associated malignant B-cell lymphoma, other lymphomas, and gastric adenocarcinoma. HPV accounts for more than half of the total infection-attributable cancers in women worldwide, resulting in cervical, as well as other genital cancers. HPV types 16 and 18 cause the majority of cancers. HPV infects epithelial cells and mutations lead to cancer.

Human herpesvirus type 8 is linked to Kaposi sarcoma, and human T-cell lymphotropic virus type 1 is linked to leukemia and lymphoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss the impact of physical activity on cancer development.

A

Regular exercise is reported to decrease the risk of breast cancer, colon cancer (men), and endometrial cancer independent of weight changes. Several biologic mechanisms have been proposed to account for the protective effect of exercise against many forms of cancer, including:
- Decreasing insulin and IGF levels
- Decreasing obesity
-Increasing free radical scavenger systems
- Altering inflammatory mediators
- Decreasing levels of circulating unbound sex hormones and metabolic hormones
- Improving immune function
- Decreasing oncogenes
-Enhancing cytochrome P-450 and thereby modifying carcinogen activation
- Increasing gut motility and excretion of carcinogens
- Increasing antitumor effects from the release of myokines or proteins from contracting muscles

After a cancer diagnosis, physical activity is associated with improved cancer-specific and overall survival with early-stage breast, prostate, and colorectal cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define Mutation

A

Mutations means alteration in the DNA sequence affecting expression or function of a gene and includes:

  • Point mutations: which are small-scale changes in DNA that involve the alteration of one or more nucleotide base pairs resulting in sometimes profound effects on the activity of resultant proteins
  • Chromosome translocations: large changes in chromosome structure in which a piece of one chromosome is translocated to another chromosome
  • Gene amplification: is the result of repeated duplication of a region of a chromosome; instead of the normal two copies of a gene, tens or even hundreds of copies are present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define clonal proliferation.

A

Also known as clonal expansion, is when cancer cells have selective advantage as their progeny accumulate faster than their non-mutated neighbors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Define malignant transformation.

A

The process by which a normal cell becomes a cancer cell, and is directed by progressive accumulation of genetic changes that alter the basic nature of the cell and drive it to malignancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Discuss sustained proliferative signaling.

A

The first and prime hallmark of cancer is uncontrolled cellular proliferation. Normal cells generally only enter proliferative phases in response to growth factors that bind to specific receptors on the cell surface. The cytoplasmic components of the receptors send signaling molecules that activate intracellular pathways leading to induction/activation of regulatory factors affecting DNA synthesis, entrance into the cell cycle, and changes in expression of other genes related to cell metabolism for optimal growth. One example is initiation of proliferation by epidermal growth factor (EGF). EGF binds and cross-links two EGF receptors on the cell surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Discuss evading growth suppressors.

A

Uncontrolled cancer cell proliferation also is related to inactivation of tumor-suppressor genes. Tumor-suppressor genes normally regulate the cell cycle, inhibit proliferation resulting from growth signals, stop cell division when cells are damaged, and prevent mutations. Therefore, they also have been referred to as anti-oncogenes. Whereas oncogenes are activated in cancers, tumor suppressors must be inactivated to allow cancer to occur. A single genetic event can activate an oncogene because it can act in a dominant manner in the cell. However, we have two copies of each tumor-suppressor gene, one from each parent. Both copies must be inactivated; thus, two mutations are necessary (homozygous mutations, also called loss of heterozygosity).

The most mutated gene in many human cancers is the p53 tumor-suppressor gene (TP53). TP53 missense mutations are the most common mutation in human cancers. The protein p53 acts as a tumor suppressor, which means it regulates cell division by restricting cells from growing and dividing too fast or in an uncontrolled way; thus, it is called the guardian of the genome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Discuss genomic instability.

A

Genomic instability is an increased tendency of alterations - mutability - in the genome during the life cycle of cells. Inherited and acquired mutations in caretaker genes that protect the integrity of the genome and DNA repair increase the level of genomic instability and risk for developing cancer.

Three key genetic mechanisms have a role in human carcinogenesis:

  1. Activation of proto-oncogenes, resulting in hyperactivity of growth-related gene products (called oncogenes)
  2. Mutation of genes, resulting in the loss or inactivity of gene products that would normally inhibit growth (called tumor-suppressor genes)
  3. Mutation of genes, resulting in over-expression of products that prevent normal cell death or apoptosis, thus allowing continued growth of tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Discuss oncogenes & tumor-suppressor genes.

A

The genes that encode components of receptor-mediated pathways designed to regulate normal cellular proliferation are collectively called proto-oncogenes. Cancerous cells characteristically express mutated or overexpressed proto-oncogenes, which are called oncogenes.

Oncogenes are independent of normal regulatory mechanisms; thus, the cell is driven into a state of unregulated expression of proliferation signals and uncontrolled cell growth.

Tumor-suppressor genes encode proteins that, in their normal state, negatively regulate proliferation. They are also referred to as anti-oncogenes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Discuss tumor induced angiogenesis.

A

An important component of wound healing is the process of establishing new blood vessels within the tissue undergoing repair (called neovascularization or angiogenesis). Access to a blood supply also is obligatory for the growth and spread of cancer. Without a blood supply to deliver oxygen and nutrients, growth of a tumor is limited to about a millimeter in diameter. Angiogenic factors and angiogenic inhibitors typically control development of new vessels. In cancerous tumors, several mechanisms increase and maintain secretion of angiogenic factors by the cancer cells and prevent release of angiogenic inhibitors. Hypoxia-inducible factor-1α (HIF-1α), an oxygen-sensitive transcription factor, is a primary regulator of angiogenesis in normal tissue; HIF-1α is stabilized under hypoxic conditions and induces expression of pro-angiogenic factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Inactivation of tumor-suppressor genes or increased expression of oncogenes (e.g., HER2) leads to increased expression of HIF-1α–regulated angiogenic factors and increased vascularization. The vessels formed within tumors differ from those in healthy tissue. They originate from endothelial sprouting from existing capillaries and irregular branching, rather than regular branching seen in healthy tissue. The interendothelial cell contact is less tight, so the vessels are more porous and prone to hemorrhage and allow passage of tumor cells into the vascular system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Discuss telomeres & replication immortality.

A

A hallmark of cancer cells is their immortality; they seem to have an unlimited life span and will continue to divide for years under appropriate laboratory conditions. Most normal cells are not immortal and can divide only a limited number of times (known as the Hayflick limit) before they either enter senescence (cease dividing) or enter crisis (apoptosis) and die. One major block to unlimited cell division (i.e., immortality) is the size of a specialized structure called the telomere. Telomeres are protective ends, or caps, of repeating hexanucleotides (six nucleotide units) on each chromosome and are placed and maintained by a specialized enzyme called telomerase. telomerase is usually active only in germ cells (in ovaries and testes) and in stem cells. All other cells of the body lack telomerase activity. Thus, when non–germ cells begin to proliferate abnormally, their telomere caps shorten with each cell division. Short telomeres usually signal the cell to cease cell division. If the telomeres become critically small, the chromosomes become unstable and fragment, and the cells die. Cancer cells are very heterogeneous, and many cells die as the cancer develops. When they reach a critical age, most cancer cells reactivate telomerase to restore and maintain their telomeres, thereby allowing continuous division. Telomerase not only maintains telomere length, but it also affects DNA replication, cellular apoptosis, tumorigenesis, and resistance to therapy by cancer cells, including those of breast and cervical origin. Cancer cells move closer to immortality by upregulating telomerase and downregulating tumor suppressor genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Discuss how cancers avoid cell death.

A

Programmed cell death (apoptosis) is a mechanism by which individual cells can self-destruct under conditions of tissue remodeling or as a protection against aberrant cell growth that may lead to malignancy. Two pathways may trigger apoptosis. The intrinsic pathway (mitochondrial pathway) monitors cellular stress. Cellular stress may include DNA damage, genomic instability, aberrant proliferation, loss of adhesion to ECM or to adjacent cells, and other causes and characteristics of abnormal cellular physiology. The extrinsic pathway is activated through a plasma membrane receptor complex linked to intracellular activators of apoptosis (known as the death receptor). Apoptotic pathways are dysregulated in most cancers. Most commonly, loss-of-function mutations to the TP53 gene suppress activation of apoptosis during DNA damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Discuss resistance to destruction in cancer.

A

The inflammatory response contributes to the onset of cancer, and cancer is a cause of chronic systemic and local inflammation. Tumors can manipulate the inflammatory process in their local tumor microenvironment to benefit tumor progression and spread. Cancer also causes systemic perturbations in both innate and adaptive immune processes that reduce the body’s ability to fight the cancer. Active inflammation predisposes a person to cancer by stimulating a wound-healing response that includes proliferation and new blood vessel growth - angiogenesis, which is part of the normal inflammatory response. Some organs are more susceptible than others and that includes those that undergo the cell cycle frequently (i.e., GI, pancreas, thyroid, prostate, urinary bladder, skin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Discuss the immune surveillance hypothesis.

A

Based on the processes of adaptive immunity, cancer cells are abnormal and should be recognized and removed from the body.The immune surveillance hypothesis predicts that most developing malignancies are suppressed by an efficient immune response against antigens found on cancer cells. The development of cancer suggests evasion of the immune response.

28
Q

Discuss the immunotherapy hypothesis.

A

The immunotherapy hypothesis predicts that the immune system could be used to target tumor-associated antigens and destroy tumors clinically.

29
Q

Discuss local spread in cancer invasion.

A

Local spread is a prerequisite for metastasis and the first step in the metastatic process. Cancer often spreads first to regional lymph nodes through the lymphatic system and then to distant organs through the blood stream. Invasion then requires that the cancer attach to specific receptors and survive the specific environment.

30
Q

Discuss Epithelial-Mesenchymal Transition (EMT).

A

EMT is the developmental (transdifferentiation) process whereby transformed epithelial cells lose their cell polarity and cell-cell adhesion, and gain the ability to invade, resist stress, and disseminate. Usually, epithelial cells are immobile and tightly bound to each other by tight junctions, gap junctions, and adherens junctions and to the neighboring EMC. EMT is a reversible biochemical process that permits a specific epithelial cell to attain a mesenchymal phenotype, such as a stem cell, which is critical for cancer progression and metastasis

31
Q

Discuss cancer invasion & metastasis.

A

Cancer cells secrete protease enzymes that digest their immediate environment, including the extracellular matrix and basement membranes - thus, creating pathways through which cells can move. Metastatic cells must be able to withstand the physiologic stresses of travel in the blood and lymphatic circulation, and then must also survive their new environment. Cancer metastasis follows these steps, in order:

  1. Cancer cells invade local blood and lymphatic vessels
  2. After release from the ECM and digestion of basement membranes, mobile cancer cells gain access to the circulation
  3. Once in the circulation, metastatic cells must be able to withstand the physiologic stresses of travel in the blood and lymphatic circulation, including high shear rates and exposure to immune cells
  4. Neovascularization of a cancer offers malignant cells direct access into the venous blood and draining lymphatic vessels
  5. Once metastasized, cancer cells may establish metastatic lesions in new locations
32
Q

Define anaplastic

A

Very little resemblance to the cells they originated from (loss of differentiation)

33
Q

Define pleomorphic

A

variable size, shape and structure - no consistency in size

34
Q

What characteristics are typical of cancer cells?

A

Cancer cells are considered anaplastic (loss of differentiation) and pleomorphic (variable size and structure) with a substantial amount of stroma (microenvironment) and disorganized with loss of normal tissue structure. They often lack a capsule and they are capable of invading nearby vessels, lymphatics, surrounding structures and metastasizing.

35
Q

Define Carcinoma in Situ

A

Considered pre-invasive epithelial malignant tumors of glandular or squamous origin. They have not yet broken through the basement membrane or invaded the surrounding stroma and as such, are not yet considered malignant. Three prognoses are available:

  1. Can remain stable for a long time
  2. Can progress to invasive and metastatic cancers
  3. Can regress and disappear
36
Q

Describe the clinical manifestations of cancer.

A

The clinical manifestations of cancer are numerous and depend on the localization and type of tumor, and some are apparent before actual diagnosis of a malignancy. They include paraneoplastic syndromes and cachexia, as well as pain, anemia, thrombocytopenia, leukopenia, and a risk of sepsis.

37
Q

Discuss screening tests and diagnostics for cancer.

A

Screening tests involve early recognition of cancer in an asymptomatic population through observation, palpation, procedures, and lab tests. Examples might include: physical exams, blood tests, pelvic and digital rectal exams, pap smears, mammograms, and colonoscopies. Screening may help prevent cancer by finding changes in the body that would become cancer if left untreated. The earlier a cancer is detected, the better a person’s chances of survival. Limitations of regular cancer screening include:
* false positives
* false negatives
* over diagnosis
* tests and procedures more harmful than the cancer

Diagnostic tests are performed when symptoms (i.e., abnormal bleeding, lumps, pain, etc.) raise concerns that cancer could be present. They are often conducted as a follow-up to a screening procedure that may have found signs of cancer and are used to establish a presence/absence of disease in symptomatic individuals. Examples include endoscopic exams (i.e., colonoscopy with tumor biopsy), biopsy, bone scan, sputum cytology, bone marrow aspiration, tumor markers, cytogenic analysis.

38
Q

Differentiate between staging and grading of cancer and explain their significance to disease management.

A

Staging: once the cancer is diagnosed, it needs to be determined if there has been spread to other areas of the body - this is known as the “stage” of cancer. Staging involves determining:
* the size of the tumor
* degree to which it has invaded
* extent of the spread
This information helps us to decide how to progress with treatment!

Stage 1: is confined to its organ of origin
Stage 2: is locally invasive
Stage 3: has advanced to regional structures
Stage 4: has spread to distant sites

Grading describes the appearance of possible cancer cells compared to that of the normal parent cells.
Normal cells are highly differentiated
* fully mature
* look like parent cells
* carry out functions of parent cell

Cancer cells gradually change
* less differentiated in structure and function
* looks very different than the parent cell
* does not carry out functions of parent cell

Grading does not always change treatment plan; will depend on the type of cancer.

Grade 1: cells are differentiated and very similar to parent cells; best prognosis
Grade 4: cells are grossly abnormal and clearly different from normal cells; worst prognosis

Grading is limited! The tumor may have some cells that look almost normal and others that are grossly abnormal - for example, some areas may be G2, while other areas of the tumor may be G4. Grading may change over time as turnover evolves.

39
Q

Explain the cell cycle and the cell kill hypothesis as it relates to cancer management.

A

The Cell Cycle: the reproduction, or division of somatic cells involves two sequential phases - mitosis and cytokinesis. However, before a cell can divide, it must double its mass and duplicate its contents. Most of the work preparing for division occurs during the growth phase, called interphase. The four designated phases of the cell cycle are 1) G1 phase: which is the period between the M phase and the start of DNA synthesis; 2) the S phase, in which DNA is synthesized in the cell nucleus; 3) the G2 phase, in which RNA and protein synthesis occurs, the period between the completion of DNA synthesis and the next phase (M); and 4) the M phase, which is mitosis, and includes both nuclear and cytoplasmic division. Mitosis consists of, in order, prophase (formation of chromosomes), metaphase (lining up of chromosomes), anaphase (chromosomes begin to separate), Telophase (cell begins to separate into two daughter cells); Cytokinesis (cell division is completed).

The Cell Kill Hypothesis: is a theoretical model that predicts the ability of antineoplastic drugs to eliminate cancer cells (a certain percentage rather than a number). If a large enough percentage of tumor cells are killed, the body’s defenses can kill the rest. For a client’s cancer to be cured, every single cell in a malignant tumor must be eliminated from the body. Leaving even one single cancer cell could result in regrowth of the tumor.

40
Q

Discuss the principles of cancer management regimes including adjuvant and neoadjuvant therapies.

A

Until late in the last century the mainstays of cancer therapy have been surgery, chemotherapy, and radiation therapy. These approaches have been highly successful for certain types of cancer but have many limitations. Evidence has long been emerging that the immune system, in particular T cells, is capable of waging war on cancer tissue—Immunotherapy.

Surgery: Surgery is often the definitive treatment of cancers that do not spread beyond the limits of surgical excision. It also is indicated for the relief of symptoms, for instance, those caused by tumor mass obstruction. In selected high-risk diseases, surgery plays a role in the prevention of cancer. Key principles apply specifically to cancer surgery, including obtaining adequate surgical margins during a resection to prevent local recurrences, placing needle tracks and biopsy incision scars (that may be contaminated with cancer cells) carefully so they can be removed in subsequent incisions, avoiding the spread of cancer cells during surgical procedures through careful technique, and paying attention to obtaining adequate tissue specimens during biopsies so that the pathologist can be confident of the diagnosis.

Radiation Therapy: Radiation therapy is used to kill cancer cells while minimizing damage to normal structures. Ionizing radiation damages cells by imparting enough energy to cause molecular damage, especially to DNA. The damage may be lethal, in which the cell is killed by radiation; potentially lethal, in which the cell is so severely affected by radiation that modifications in its environment will cause it to die; or sublethal, in which the cell can subsequently repair itself. Areas with rapidly renewing cells are more radiosensitive. Effective cell killing by radiation also requires good local delivery of oxygen, something not always present in large cancers. Radiation produces slow changes in most cancers and irreversible changes in normal tissues as well. Because of these irreversible changes, each tissue has a maximum lifetime dose of radiation it can tolerate. Radiation is well suited to treat localized disease in areas that are hard to reach surgically. Several radiation delivery methods are available, with external beam being the most common. Radiation sources, such as small 125I-labeled capsules (also called seeds), can also be temporarily placed into body cavities, a delivery method termed brachytherapy. Brachytherapy is useful in the treatment of cervical, prostate, and head and neck cancers.

41
Q

Discuss management of the adverse effects of cancer treatments including nausea and nasir.

A

Antineoplastic agents affect cells that are undergoing rapid mitosis, thus healthy cells that undergo rapid mitosis are also affected.

Hematologic
* Nadir: during treatment, there will be a period of greatest bone marrow suppression/myelosuppression where blood cell counts are extremely low and results in reduced production of RBCs, WBCs, and platelets. Cell counts will begin to recover once that phase of therapy is over.

GI
* Nausea and vomiting are also common side effects as agents can reach and trigger chemo sensitive zones in the brain; antineoplastics are sometimes classified by their “emetic potential”.

  • Mucositis involves inflammation of the mucosa and promotes ulcerations of the mouth and esophagus, may cause difficulty with eating and swallowing.
  • Constipation, diarrhea, anorexia, and cachexia are also common side effects

Skin
* Extravasation of many antineoplastic drugs can cause serious tissue injury; many are vesicants causing blistering/tissue damage.
* Alopeica

Reproductive
* Alkylating agents in particular are associated with infertility
* Sterility risk higher in males
* Pregnancy category X

Other
* Fatigue - may be attributed to hematologic effects, GI effects, anxiety and depression, but also repairing and regenerating healthy cells requires energy
* Secondary malignancy is uncommon, however, antineoplastic agents have been known to cause other tumors to develop while primary tumor is treated. Can result from immune suppression and damaged DNA from radiation can cause more mutations in other areas

42
Q

Discuss biotherapy, immunotherapy, and the emergence of targeted therapy.

A

Immunotherapy is the expression of unique antigens on cancer cells that can be targeted by T cells. These therapies can initiate the immune response, boost an inadequate immune response, and convert a tumor-protective immune response into a destructive one.

Immunomodulators are agents that stimulate the body’s immune system to kill tumor cells. They include interferons and interleukins.
* Interferons SUPPRESS cell division in certain cancers and activate macrophages and T cytotoxic cells (they interfere!)
* Interleukins PROMOTE actions of the immune response such as IL-2 which activates cytotoxic T cells. It is indicated for metastatic and renal carcinoma (they bring interlopers to help!)

Targeted Therapy is designed to address unique growth characteristics of a tumor and directly interfere with that process. Tumor growth and progression are dependent on a variety of mutations and lead to the expression of oncogenes, inactivation of tumor-suppressor molecules, and interactions with inflammatory cells in the tumor micro-environment that foster angiogenesis, resistance to apoptosis, and immune-mediated cancer cell death, altered tumor metabolism, and metastasis. Targeted therapy involved specifically engineered molecules that attack cancer antigens, such as monoclonal antibodies. By taking the patient’s own cells and modifying them to target cancer cells you end up with a more specific therapy that is less likely to damage non-cancer cells.

43
Q

Identify the classifications of drugs used in the treatment of cancer.

A
  • Antineoplastic agents (i.e., chemotherapy)
  • Immunomodulators (i.e., interferons, interleukins)
  • Hormone antagonists/anti-estrogen (i.e., tamoxifen)
  • Monoclonal antibody (i.e., Bevacizumab)
  • Antiemetic/serotonin 5-HT3 Receptor (i.e., Ondansetron)
  • Biologic response modifiers (BRMs)/Granulocyte colony-stimulating factor (i.e., Filgrastim)
44
Q

What are paraneoplastic syndromes?

A

Paraneoplastic syndromes are rare disorders with complex clinical manifestations that are triggered by a cancer but are not caused by direct local effects of the tumor mass. In paraneoplastic syndromes, malignant cells do not cause symptoms related to metastasis, but they generate autoantibodies, cytokines, hormones, or peptides that affect many organ systems. For example, a few carcinoid tumors release hormones, including serotonin, into the blood stream that cause flushing, diarrhea, wheezing, and rapid heartbeat. Many cancers also can trigger an antibody response that attacks the nervous system, causing a variety of neurologic disorders that can show up before other symptoms of cancer by months. Although infrequent, paraneoplastic syndromes are significant because they may be the earliest symptom of an unknown cancer and, in affected individuals, can be serious, often irreversible, and sometimes life-threatening.

Examples include:
* Hypercalcemia - breast, renal, ovarian carcinomas
* Hypoglycemia - fibrosarcoma, hepatocellular carcinoma
* Polycythemia - renal, cerebellar, hepatocellular
* CNS Disorders - breast
* Dermatomyositis - bronchogenic, breast
* Clubbing of fingers - bronchogenic carcinoma
* Anemia - thymic neoplasms

45
Q

What is Cachexia?

A

Cachexia is a complex metabolic syndrome associated with basic illness and is characterized by the loss of muscle with or without loss of fat mass. Cachexia is observed in many medical conditions, however, cancer cachexia is characterized by systemic inflammation, negative protein and energy balance, and loss of lean body mass with or without wasting of adipose tissue. Although management of advanced cancers usually does not reverse cachexia, treatment of earlier cancers can reverse the cachexia syndrome. Manifestations include anorexia, early satiety, weight loss, anemia, asthenia, taste alterations, and altered protein, lipid, and carbohydrate metabolism. It is considered a multi-organ syndrome and an energy balance disorder, where energy intake is decreased, and energy expenditure is increased - how much will depend on the tumor type and its growth phase. Cachexia contributes to a loss of skeletal muscle and adipose tissue, specifically a loss of white adipose tissue which sees a “browning effect”, and changes in hypothalamic function. Alterations in liver and heart function also occur, and there is thought to be a possible gut-microbiota-skeletal muscle relationship.

Inflammation plays a significant role in muscle wasting and is linked to alterations in protein and amino acid metabolism, activation of muscle cell apoptosis, and decreased regeneration.

46
Q

Discuss the role and experience of pain in cancer.

A

Pain may occur during the early stages of malignant disease, but typically intensifies with disease progression. It can be a result of:

  • Direct pressure (i.e., a large tumor pressing on organs, nerves, etc.)
  • Obstruction (i.e., G.I obstruction)
  • Invasion of a sensitive structure (i.e., axilla vs. abdomen - typically impacting highly innervated areas)
  • Stretching of visceral surfaces
  • Tissue destruction (the cancer is literally eating its way through its environment)
  • Infection (immunocompromised)
  • Inflammation - chronic pain may result from nerve damage secondary to surgery, chemotherapy, or radiation
47
Q

Discuss the role and experience of anemia in cancer.

A

Anemia, a condition in which the body does not have enough healthy red blood cells, is common in cancer - with up to 20% of individuals diagnosed with cancer having low HgB. There are several suspected causes, some of which include:
* iron deficiency and chronic bleeding
* malignancy in blood forming organs
* malabsorption of iron in gastric, pancreatic or intestinal cancer
* malnutrition
* chemotherapy

48
Q

Discuss the role and experience of thrombocytopenia in cancer.

A

Thrombocytopenia, is a condition that occurs when the platelet count in your blood is too low (<100,000/mm3). As a result, the individual may experience prolongation of normal clotting but is usually not at risk for spontaneous major bleeding episodes unless the platelet count falls below 20,000/mm3. Thrombocytopenia may develop if the bone marrow isn’t working normally and doesn’t make enough platelets. Some cancers, such as leukemia can cause thrombocytopenia. The following cancer treatments can also affect the bone marrow and lead to a low platelet count: chemotherapy drugs, biological therapies, and some other drugs.

49
Q

Discuss the role and experience of Leukopenia in cancer.

A

Leukopenia is a decrease in the total number of white blood cells (<4000 cells/uL). In cancer, it is specifically associated with a decrease in the number of neutrophils, which increase the risk for infection. The possibility for life-threatening infections is high.

50
Q

Discuss the risk of sepsis in cancer.

A

The most significant cause of complications and death in people with malignant disease is infection. As a result of immune suppression, lymphopenia, and granulocytopenia, resulting from the underlying cancer or secondary to treatment, the risk for serious microbial (bacterial and fungal) infections is high. The prevalence of hospital-acquired infections increases because of indwelling medical devices, inadequate wound care, and the introduction of microorganisms from visitors and other individuals. Risk of sepsis is predisposed by:
* Age (immunological functions decline and immobility increases risk, as well as malnutrition)
* Tumor
* Leukemias (inadequate granulocyte production, thrombocytopenia)
* Lymphomas and other mononuclear phagocyte malignancies (humoral and cellular immune deficits)
* Surgical treatment (invasive procedure that interrupts first line of defense)

51
Q

Discuss the WHO’s standardized TNM staging system

A

T indicates tumor spread
* describes size of main/primary tumor
* given as a number form 1 to 4
* a higher number means the tumor is larger
N indicates node involvement
* describes whether cancer has spread to lymph nodes around the organ
* N0 means the cancer has not spread to any nearby lymph nodes
* N1, N2, or N3 means cancer has spread to lymph nodes
* N1 to N3 also describes the number of lymph nodes that contain cancer as well as their size and location
M indicates presence of distance metastasis
* describes whether the cancer has spread to other parts of body through blood or lymphatic system
* M0 means that cancer has not spread to other part of the body
* M1 means that it has spread to other parts of the body

The prognosis generally worsens with increasing tumor size, lymph node involvement, and metastasis. Staging may also alter the choice of therapy, more aggressive therapy is deliver to more invasive disease.

52
Q

What are tumor markers?

A

During surveillance or diagnosis of cancer, as well as following therapy, specific biochemical markers of tumors have proven to be helpful. These tumor markers are substances produced by both benign and malignant cells that are either present in or on tumor cells or found in blood, spinal fluid, or urine. Tumor markers include hormones, enzymes, genes, antigens, and antibodies. For example, the tumor-associated antigen carcinoembryonic antigen (CEA) is released from colon cancer. If the tumor marker itself has biologic activity, then it can cause symptoms. Tumor markers can be used in three ways: (1) to screen and identify individuals at high risk for cancer; (2) to help diagnose the specific type of tumor in individuals with clinical manifestations relating to their tumor, as in adrenal tumors or enlarged liver or prostate; and (3) to follow the clinical course of a tumor.

53
Q

Discuss chemotherapy in cancer treatment

A

All chemotherapeutic agents take advantage of specific vulnerabilities in target cancer cells, with the goal of eradicating enough tumor cells to enable the body’s natural defenses to attack and destroy remaining cancer cells. Chemotherapy treatments can be single-agent or combination, however, single chemotherapeutic agents often shrink cancers but given alone rarely provide a cure. Induction chemotherapy seeks to cause shrinkage or disappearance of tumors. Adjuvant chemotherapy is given after surgical excision of a cancer with the goal of eliminating micrometastases, or cancerous cells that were not removed during surgery. Neoadjuvant chemotherapy is given before localized (surgical or radiation) treatment of a cancer to reduce the size of a tumor for a more manageable and less invasive surgery. Chemoprophylaxis involves taking a drug to lower cancer risk, for example, tamoxifen in the case of breast cancer risk.

Chemotherapy works by travelling through the blood, making it more effective at reaching cancer cells. It kills cells undergoing rapid mitosis, but this also unfortunately includes cells of the skin, hair, GI tract, and mouth. It can be used with surgery and radiation to maximize chances of eradicating all tumor cells, and may be used in palliative care to decrease pain and increase QOL.

54
Q

What is growth fraction, and why does it matter?

A

Growth fraction is the measure of cells undergoing mitosis, the ratio of number of replicating cells to resting cells. This matters because antineoplastic agents are more effective on tumors with high growth fractions.

55
Q

How should the nurse respond if infiltration/extravasation of drugs with vesicant properties occurs?

A
  • stop infusion immediately upon recognition of extravasation
  • disconnect administration line, but leave cannula in place
  • monitor site of injury, elevate limb
  • if necessary, flush affected tissue with saline (may sometimes be contraindicated)
  • document incident
  • contact appropriate personnel
56
Q

What drugs may be used in the treatment of cancer-related adverse effects?

A

Antiemetic/Glucocorticoid: dexamethasone

Antiemetic/Serotonin 5-HT3 receptor antagonist: ondansetron

Biologic response modifier (BRM)/Granulocyte colony-stimulating factor (GCSF): Filgrastim
* stimulate production of leukocytes
* used following chemotherapy
* control of WBC production depends on interleukins and CSFs
* CSFs are named by type of cells being stimulated (e.g., GCSF)

57
Q

What is Filgrastim?

A

Filgrastim is a Biological Response Modifier/Colony-Stimulating Factor

Indication: Neutropenia
Mechanism of Action: increases neutrophil (most common type of granulocyte) production in bone marrow and enhances phagocytic and cytotoxic functions of existing neutrophils.
Desired Effect: shorten length of neutropenia in clients with cancer whose bone marrow has been suppressed by antineoplastic agents
Adverse Effects: bone pain, allergic reaction

58
Q

What is Dexamethasone?

A

Dexamethasone is an Antiemetic/Glucocorticoid.

Indication: management of nausea and vomiting associated with emetogenic chemotherapy.
Mechanism of action: antagonizes serotonin receptors
Desired effects: reduces nausea and vomiting related to cancer treatment; reduced weight loss (by stimulating appetite); reduces tissue inflammation
Adverse effects: fluid retention, poor wound healing, thrombocytopenia, infections

59
Q

Why are we more likely to give Ondansetron preventatively than Dexamethasone for cancer-treatment related nausea and vomiting?

A

Dexamethasone has adverse effects that include poor wound healing and thrombocytopenia, which are already concerns in cancer treatment - we don’t want to make it worse.

However, Ondansetron can cause fever so it is important to be aware of this when administering.

60
Q

What is Tamoxifen?

A

Tamoxifen is a hormone antagonist/antiestrogen.

Indication: prophylaxis of breast cancer for high-risk clients; treat metastatic breast cancer; adjunctive therapy following a mastectomy to decrease potential for cancer in contralateral breast
Mechanism of action: antagonizes estrogen receptors in breast; effective against breast tumors requiring estrogen for their growth; blocks estrogen receptors in breast thus reducing tumor growth.
Adverse effects: N/V, hot flashes, rash, fluid retention, vaginal discharge, irregular menses, headaches, light-headedness
Serious adverse effects: increased risk of endometrial cancer, small increased risk of thromboembolic disease (CVA, DVT, PE)

61
Q

What is Bevacizumab?

A

Bevacizumab is a monoclonal antibody.

Indications: metastatic colorectal cancer, renal cell carcinoma, glioblastoma, non-small cell lung cancer
Mechanisms of action: binds to and inhibits activity of human vascular endothelial growth factor (VEGF) to reduce microvascular growth and inhibit metastatic disease progression
Desired effects: selectively targets cancer cells while leaving normal cells unharmed, thus decreasing tumor size and growth
Adverse effects: asthenia, dizziness, impaired wound healing

62
Q

Which statements best describe tumor grading? Select all that apply:
A. Tumor grading provides information on how tumor cells look under a microscope.
B. Cancer can be graded using the TNM classification system.
C. Tumor grading describes the location and size of the main tumor, and if the cancer has spread to other parts of the body like the lymph nodes or other organs.
D. A biopsy is used to help grade a tumor.

A

The answers are A and D. These options are correct regarding tumor grading. Options B and C describes cancer staging.

63
Q

Your patient’s tumor grading report stated “well differentiated, Grade I”. You know that this means?
A. The patient’s tumor cells were different in appearance and arrangement compared to what normal cells possess.
B. This type of cancer is considered high grade.
C. This type of cancer is low grade because the tumor cells have an appearance and arrangement that is similar to normal cells.
D. This grade of cancer tends to spread and grow quickly.

A

The answer is C.

64
Q

A tumor was shown to possess cells that were moderately differentiated. This is considered a?

A

Grade II

65
Q

The TNM staging system has been used to stage your patient’s cancer. The report says: T1N0M0 What is the meaning of N0?
A. Cancer in regional lymph node can’t be measured
B. No cancer present in regional lymph node
C. Cancer in distant lymph node can’t be measured
D. No cancer found in other body parts

A

The answer is B: No cancer present in regional lymph node.

66
Q

What TNM classification below best describes this finding: very large tumor with 1 regional lymph node involvement, and spread to two regional organs?
A. T1N1M2
B. T4N1M1
C. T1N1M1
D. T4N1M2

A

The answer is B. T4N1M1

67
Q

Which TNM classification has the poorest prognosis?
A. T0N0M0
B. T2N2M1
C. T4N1M0
D. T4N3M1

A

The answer is D: T4N3M1

68
Q

Which stage of cancer is called metastatic cancer and means the cancer has spread to other parts of the body beyond where the cancer started?
A. Stage II
B. Stage 0
C. Stage III
D. Stage I
E. Stage IV

A

The answer is E: Stage IV